Shanghai Changzheng Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1955-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.shczyy.com
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06092112
Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 118
- Registration Number
- NCT06078969
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
The Observation on the Efficacy of Dual Therapy Based on Vonoprazan in Eradicating Helicobacter Pylori
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 400
- Registration Number
- NCT06004401
A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's Macroglobulinemia
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-07
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05979948
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Study of FasT CAR-T GC012F Injection NDMM Patients
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT05840107
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, Shanghai, China
Study of CT071 Injection in RRMM or PPCL
Early Phase 1
Recruiting
- Conditions
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT05838131
- Locations
- 🇨🇳
Shanghai Changzheng Hospital, Shanghai, China
Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
Phase 4
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2023-04-05
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT05799716
mNGS for Therapy of Urinary Infectious Diseases
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-11-22
- Last Posted Date
- 2022-11-22
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 72
- Registration Number
- NCT05624476
Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-20
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05588297
Preoperative Pembrolizumab Plus Bevacizumab Combined With Chemotherapy in Patients With pMMR/MSS Locally Advanced Colorectal Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-19
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Shanghai Changzheng Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT05585814
© Copyright 2024. All Rights Reserved by MedPath